Edit Entry | Edit CV

Patricia A. Pioli, PhD

Title(s)
Associate Professor of Microbiology and Immunology

Additional Titles/Positions/Affiliations
NCCC Member

Department(s)
Microbiology and Immunology

Education
Dartmouth Medical School, Ph.D. 2001
George Washington University, B.S. 1993

Programs
Immunology Program
Molecular and Cellular Biology Graduate Programs
Program in Experimental and Molecular Medicine

Websites
https://geiselmed.dartmouth.edu/pioli/

Contact Information

Dartmouth Medical School
HB 7556
Lebanon NH 03756

Office: 644E Borwell Building
Phone: 603-650-2584
Fax: 603-650-6130
Email: pioli@dartmouth.edu


Professional Interests

autoimmunity, cancer immunotherapy, molecular immunology, endocrinology

Rotations and Thesis Projects

1. Determine how aberrant regulation of miRNAs affects activation of macrophages in autoimmune systemic sclerosis (scleroderma)

2. Identify the role that macrophages play in the immune/fibrotic axis in scleroderma

3. Determine how modulation of the tumor immune landscape (microenvironment) can be used to combat cancer

Biography

Dr. Pioli received a B.S. in biology from George Washington University in 1993 and a Ph.D. in biochemistry from Dartmouth Medical School in 2001. She performed post-doctoral research with Dr. Paul Guyre at Dartmouth from 2001-2004, studying the mechanisms by which cortisol influences macrophage activation and immune function. She was appointed Research Assistant Professor of Physiology from 2004-2010. In July 2010, Dr. Pioli joined the faculty of Dartmouth Medical School as Assistant Professor in the Department of Obstetrics and Gynecology and Microbiology and Immunology.


Selected Publications

 

A streamlined and comprehensive protocol for the generation and multi-omic analysis of human monocyte-derived macrophages.
Palmer OG, Perreard L, Kolling Iv FW, Pioli PA, Goods BA
BMC Biotechnol. 2025 Dec 29;25(1):141. doi: 10.1186/s12896-025-01071-4. Epub 2025 Dec 29.
PMID: 41466393

Multimodal Analyses of Early, Untreated SSc Skin Identify a Proinflammatory Vascular Niche of Macrophage-Fibroblast Signaling.
Jarnagin HC, Parvizi R, Gong Z, Gedert R, Xing X, Tsoi LAC, Bogle R, Morrisson MJ, Perreard L, Pioli PA, Kolling Iv F, Gudjonsson JE, Khanna D, Whitfield ML
JCI Insight. 2025 Dec 18; pii: e198954. doi: 10.1172/jci.insight.198954. Epub 2025 Dec 18.
PMID: 41411065

RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis.
Parvizi R, Gong Z, Jarnagin HC, Toledo DM, Abel TR, Popovich D, Morrisson MJ, Wood TA, Shenk S, Sarkar MK, Plazyo O, Dey P, Coon A, Erba JM, Tsoi LC, Tsou PS, Hinchcliff ME, Khanna D, Garlick JA, Gudjonsson JE, Pioli PA, Whitfield ML
Ann Rheum Dis. 2025 Dec 10; pii: S0003-4967(25)04525-X. doi: 10.1016/j.ard.2025.10.033. Epub 2025 Dec 10.
PMID: 41381303

Anti-CD206 CAR T Cell Treatment Restores Fibrosis-Induced Loss of Dermal White Adipose Tissue.
Park C, Mohamed AO, Jarnagin HC, Bhandari R, Gunn J, Murad-Mabaera J, Kosarek NN, Kolling FW, Wilkins OM, Huang YH, Whitfield ML, Pioli PA
bioRxiv. 2025 Oct 16; pii: 2025.10.16.682860. doi: 10.1101/2025.10.16.682860. Epub 2025 Oct 16.
PMID: 41279642

T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models.
Singh I, Morrisson M, Shenk S, Jarnagin H, Hauer J, Lobo A, Brown L, Houck T, Altman-Sagan L, Pioli PA, Whitfield ML, Garlick JA
Tissue Eng Part C Methods. 2025 Jul;31(7):248-260. doi: 10.1177/19373341251360742.
PMID: 40690724

A streamlined and comprehensive protocol for the generation and multi-omic analysis of human monocyte-derived macrophages.
Palmer OG, Perreard L, Kolling FW, Pioli PA, Goods BA
bioRxiv. 2025 May 30; pii: 2025.05.30.655544. doi: 10.1101/2025.05.30.655544. Epub 2025 May 30.
PMID: 40501670

Geographic Clustering of Systemic Sclerosis in Areas of Environmental Pollution.
Kosarek NN, Romano ME, Moen EL, Simms RW, Erickson A, Khanna D, Pioli PA, Whitfield ML
Arthritis Care Res (Hoboken). 2025 Jul;77(7):855-866. doi: 10.1002/acr.25504. Epub 2025 Feb 28.
PMID: 39895067

Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages.
Morris EA, Parvizi R, Orzechowski NM, Whitfield ML, Pioli PA
Rheumatology (Oxford). 2025 May 1;64(5):3125-3133. doi: 10.1093/rheumatology/keae517.
PMID: 39312626

Single-cell epigenomic dysregulation of Systemic Sclerosis fibroblasts via CREB1/EGR1 axis in self-assembled human skin equivalents.
Abel TR, Kosarek NN, Parvizi R, Jarnagin H, Torres GM, Bhandari R, Huang M, Toledo DM, Smith A, Popovich D, Mariani MP, Yang H, Wood T, Garlick J, Pioli PA, Whitfield ML
bioRxiv. 2024 Mar 27; pii: 2024.03.22.586316. doi: 10.1101/2024.03.22.586316. Epub 2024 Mar 27.
PMID: 38585776

CDDO-Methyl Ester Inhibits BRAF Inhibitor Resistance and Remodels the Myeloid Compartment in BRAF-mutant Melanoma.
Torres GM, Jarnagin HC, Park C, Yang H, Kosarek NN, Bhandari R, Wang CY, Kolling FW, Whitfield ML, Turk MJ, Liby KT, Pioli PA
bioRxiv. 2023 Aug 3; pii: 2023.08.01.551524. doi: 10.1101/2023.08.01.551524. Epub 2023 Aug 3.
PMID: 37577680

View more publications on PubMed